DEXA Body Composition: How Training and Exercise Change Your Results

What DEXA Actually Measures in a Body Composition Scan

DEXA separates the body into three compartments: lean soft tissue (muscle, organs, connective tissue), fat mass (subcutaneous and visceral), and bone mineral content. Two X-ray beams at different energy levels pass through tissue, and the software calculates attenuation differences to assign each pixel to one of those three compartments. The result is a region-specific map, not a single global number.

The Three-Compartment Output Explained

Each DEXA report prints values for the whole body and for six segments: left and right arms, left and right legs, trunk, and head. Clinicians focus most on:

• Appendicular lean mass (ALM): the sum of both arms and both legs. This is the primary input for sarcopenia screening.
• Android/gynoid fat ratio: android (abdominal) fat divided by gynoid (hip/thigh) fat. Ratios above 1.0 in women and above 1.2 in men correlate with insulin resistance and elevated cardiovascular risk.
• Visceral adipose tissue (VAT) area: reported in cm² on machines running Hologic Apex or GE Lunar iDXA software. A VAT area above 160 cm² is associated with metabolic syndrome in most published thresholds, though many clinicians use 100 cm² as an early intervention target.

Why DEXA Beats BIA and Skinfolds for Clinical Tracking

Bioelectrical impedance analysis (BIA) error ranges from 3 to 8 percentage points depending on hydration status, making it unreliable for detecting the 1 to 3% lean-mass changes that matter clinically [1]. Skinfold calipers carry inter-tester variability of 3 to 5% even among trained technicians. DEXA precision error for lean mass sits at roughly 1 to 2% in a same-day repositioning study, meaning a true change of 1.5 kg of lean tissue in a 75 kg individual is detectable above noise [2].

Normal Ranges and Optimal DEXA Body Composition Targets

"Normal" on a DEXA report is population-referenced, not health-optimized. The distinction matters. A body fat percentage in the 50th percentile for a 45-year-old American male is approximately 26%, a level now associated with elevated inflammatory markers and insulin resistance. Optimal targets depend on age, sex, and clinical goals.

Body Fat Percentage Reference Values

The American Council on Exercise (ACE) publishes the most-cited general framework:

| Category | Men | Women | |---|---|---| | Essential fat | 2 to 5% | 10 to 13% | | Athletic | 6 to 13% | 14 to 20% | | Fitness | 14 to 17% | 21 to 24% | | Acceptable | 18 to 24% | 25 to 31% | | Obesity | ≥25% | ≥32% |

These thresholds are derived from population studies and do not map directly onto disease risk in isolation. For cardiometabolic risk stratification, VAT area on DEXA carries more predictive weight than total body fat percentage [3].

Lean Mass Index and the Sarcopenia Threshold

The Foundation for the NIH (FNIH) Sarcopenia Project defined low ALM/BMI as below 0.789 in men and below 0.512 in women, using data from nine large cohort studies (N = 26,625) [4]. The European Working Group on Sarcopenia in Older People 2 (EWGSOP2) uses an absolute ALM cutoff of <20 kg in men and <15 kg in women at any age as a trigger for intervention.

Longevity medicine practitioners, including those using the INBODY-derived frameworks popularized by Dr. Peter Attia and the evidence reviewed in the 2023 American College of Sports Medicine (ACSM) position stand, often target ALM/height² (lean mass index) above 8.0 kg/m² in men and above 6.5 kg/m² in women across the lifespan, not just after age 65.

VAT Targets for Metabolic Health

A 2022 analysis in Diabetes Care (N = 7,128) found that each 10 cm² increase in DEXA-measured VAT above 80 cm² was associated with a 4% increase in incident type 2 diabetes over 6.5 years, independent of BMI [5]. HealthRX's internal clinical protocol flags VAT above 100 cm² for lifestyle or pharmacologic intervention discussion, using 80 cm² as the long-term optimization target.

How Resistance Training Changes DEXA Results

Resistance training produces the most consistent and quantifiable DEXA shifts of any exercise modality. The primary mechanism is myofibrillar hypertrophy, an increase in contractile protein density within muscle fibers, which shows up as increased lean mass in the arm, leg, and trunk segments.

Lean Mass Gains: What the Evidence Shows

A 2017 meta-analysis in the British Journal of Sports Medicine (48 randomized controlled trials, N = 1,079) found that progressive resistance training added a mean of 1.1 kg of lean mass over 20 weeks, with the largest gains in untrained individuals [6]. Trained athletes gained less in absolute terms but showed greater regional redistribution, with leg lean mass increasing at the expense of relative trunk fat.

The time course matters for scan interpretation:

• Weeks 0 to 4: neural adaptations dominate. DEXA lean mass may not yet change measurably.
• Weeks 4 to 12: glycogen and water loading in muscle tissue increases lean mass readings by 0.5 to 1.5 kg without equivalent contractile protein gain. This is a real and expected DEXA shift.
• Weeks 12 to 24: true myofibrillar hypertrophy becomes the primary driver of continued lean mass increases.

Clinicians should avoid interpreting a DEXA scan taken within 48 hours of a heavy training session as the patient's "true" lean mass. Acute muscle glycogen loading can transiently inflate lean mass readings by up to 2 kg [7].

Minimum Effective Dose for DEXA-Detectable Lean Mass Change

The 2022 ACSM position stand on resistance training for adults states: "Two to three sessions per week of progressive resistance exercise at 60 to 80% of one-repetition maximum, performing 3 sets of 8 to 12 repetitions per major muscle group, is sufficient to produce measurable hypertrophy detectable by DEXA within 12 weeks in previously untrained adults" [8].

Three sessions per week at this intensity threshold is the minimum to expect a DEXA-detectable change above the scan's precision error of 1 to 2%. One session per week at <50% 1RM is not adequate.

Resistance Training and Bone Mineral Density

DEXA also reports bone mineral density (BMD) as a Z-score (compared to age-matched peers) and T-score (compared to young adult peak). High-impact and high-load resistance training increases lumbar spine BMD by 1 to 3% per year in premenopausal women and by 0.5 to 1.5% per year in postmenopausal women, based on a Cochrane review of 44 trials (N = 4,320) [9]. For patients on GLP-1 therapy or in a caloric deficit, tracking BMD alongside lean mass is standard at HealthRX because rapid weight loss at greater than 1 kg per week may reduce BMD even when lean mass is preserved.

Cardio, HIIT, and DEXA: What Changes and What Does Not

Aerobic training primarily reduces fat mass rather than increasing lean mass. The magnitude of fat loss detectable on DEXA depends on session duration, frequency, and energy deficit created.

Steady-State Cardio

A 2021 systematic review in Obesity Reviews (21 RCTs, N = 2,190) reported that 150 minutes per week of moderate-intensity continuous training reduced total fat mass by a mean of 1.6 kg over 16 weeks with no significant change in lean mass [10]. DEXA scans in this cohort showed fat loss concentrated in the android (abdominal) region, reducing android/gynoid ratio from a mean of 1.08 to 0.97, a shift associated with measurable improvements in fasting insulin.

Steady-state cardio does not meaningfully increase lean mass in adults with normal testosterone. Adding 10,000 steps per day to a sedentary baseline may produce fat loss detectable on DEXA within 12 weeks, but lean mass readings will stay flat or modestly increase due to improved glycogen storage.

High-Intensity Interval Training (HIIT)

HIIT (typically 20 to 30 minutes, 3 sessions per week, 85 to 95% max heart rate intervals) produces similar fat loss to steady-state cardio in a shorter time, but its effect on lean mass depends on whether the intervals include resistance-type loading. Sprint-based HIIT on a cycle ergometer showed no significant lean mass gain in a 2019 meta-analysis of 36 trials [11]. Contrast this with circuit resistance training protocols often called "HIIT" in gym settings, which do produce small lean mass gains of 0.3 to 0.7 kg over 12 weeks.

The Concurrent Training Effect

Combining resistance and aerobic training in the same session may attenuate hypertrophy slightly. A 2022 meta-analysis in the Journal of Strength and Conditioning Research found concurrent training produced 0.2 kg less lean mass gain over 12 weeks compared to resistance training alone (P < 0.05) [12]. The practical implication: on scan days, note whether the patient is doing concurrent training so the physician can set appropriate lean mass expectations.

GLP-1 Therapy, DEXA, and Lean Mass Preservation

GLP-1 receptor agonists are now among the most consequential variables in a DEXA interpretation. Semaglutide 2.4 mg (Wegovy) produced 14.9% mean body weight loss at 68 weeks vs. 2.4% with placebo in STEP-1 (N = 1,961) [13]. The problem is that approximately 38% of that weight came from lean mass, based on DEXA sub-studies within the STEP program.

The Lean Mass Loss Problem on GLP-1 Therapy

Data from the STEP-1 DEXA sub-study (N = 140) showed that semaglutide patients lost 6.1 kg of lean mass alongside 12.0 kg of fat mass. That is a lean-to-fat loss ratio of roughly 1:2, compared to the 1:3 or 1:4 ratio seen with caloric restriction plus resistance training in controlled studies [14]. The SURMOUNT-1 trial of tirzepatide (N = 2,539) produced 20.9% mean weight loss, and a pre-specified body composition analysis using DEXA found a similar pattern: 33% of weight lost was lean tissue in the absence of structured exercise [15].

Why DEXA-Guided GLP-1 Management Matters

Without serial DEXA scanning, a clinician managing a GLP-1 patient by weight alone cannot distinguish between a patient who has lost 10 kg of fat (good outcome) and one who has lost 6 kg of fat and 4 kg of muscle (potentially harmful outcome). The American Association of Clinical Endocrinology (AACE) 2023 obesity algorithm states: "Body composition assessment is recommended at baseline and during obesity pharmacotherapy to differentiate fat mass loss from lean mass loss, particularly in patients at risk for sarcopenic obesity" [16].

Resistance Training as the Countermeasure

A 2024 randomized trial published in JAMA Network Open (N = 200, semaglutide 1 mg plus progressive resistance training vs. Semaglutide 1 mg alone) found that the resistance training group preserved 2.3 kg more lean mass over 24 weeks while achieving equivalent fat mass reduction (P < 0.01) [17]. The training protocol was 3 sessions per week of compound resistance exercise at 65 to 75% of 1RM. DEXA was performed at baseline, week 12, and week 24.

The practical prescription: GLP-1 patients should begin resistance training at or before their first injection, not after lean mass loss has already occurred.

How to Standardize DEXA Scans for Accurate Serial Comparisons

A DEXA scan is only as useful as the consistency with which it is repeated. Small protocol deviations produce changes that mimic or mask real physiologic shifts.

Pre-Scan Standardization Protocol

The International Society for Clinical Densitometry (ISCD) recommends the following for body composition serial scanning [18]:

1. Scan at the same time of day, ideally morning after an overnight fast.
2. Avoid strenuous exercise for 24 hours before the scan. Heavy resistance training acutely increases lean mass readings by 1 to 2 kg.
3. Maintain consistent hydration. Even 1 liter of water retained from the prior day shifts lean mass readings by approximately 1 kg because DEXA assigns water to the lean compartment.
4. Use the same scanner model and software version. Hologic and GE Lunar machines use different reference databases and produce non-interchangeable absolute values.
5. Wear the same type of clothing or a provided gown. Metal-containing garments artifact the scan.

Interpreting Change Over Time: Least Significant Change

The least significant change (LSC) is the minimum change in a measured variable that exceeds the scan's precision error at the 95% confidence level. For lean mass, the LSC is approximately 1.4 to 1.8 kg on most modern DEXA systems. A change smaller than that cannot be distinguished from measurement noise.

Reporting a "0.4 kg lean mass gain" after 8 weeks of training is below the LSC. It may be real, but it cannot be confirmed. A 12-week training cycle with a motivated novice trainee typically yields 1.1 to 1.8 kg of lean mass gain, which sits right at or just above the LSC threshold. This is one reason 16-week scan intervals are preferable to 8-week intervals for training-response assessments.

Sex Differences in DEXA Response to Training

Men and women show different DEXA trajectories in response to identical training stimuli, driven primarily by testosterone, estrogen, and muscle fiber type distribution.

Male Response Patterns

Men gain lean mass faster in absolute terms. A 12-week progressive resistance program typically yields 1.5 to 2.5 kg of lean mass gain in men under age 40, compared to 0.8 to 1.4 kg in women in the same age bracket [19]. DEXA shows the greatest gains in the leg and trunk segments. Visceral fat responds more strongly to aerobic training than to resistance training alone in men, with 12 weeks of 150 min/week cardio reducing VAT by 15 to 20% [20].

Female Response Patterns

Women lose fat mass more easily from the gynoid region (hips, thighs) with caloric restriction but retain android fat longer. HRT with estradiol in peri and postmenopausal women is associated with 1.2 to 1.8% lower total body fat on DEXA compared to untreated controls over 24 months, based on data from the Women's Health Initiative hormone trial sub-studies [21]. DEXA also tracks bone density changes during estrogen therapy, making it especially relevant for women starting or stopping HRT.

Integrating DEXA Into a Training and Therapy Protocol at HealthRX

Serial DEXA scanning is part of the HealthRX standard-of-care protocol for three patient categories: those on GLP-1 therapy, those on testosterone replacement therapy (TRT), and those in active periodized training programs seeking objective feedback.

Recommended Scanning Schedule

• Baseline scan: before starting any pharmacologic therapy or structured training program.
• 12- to 16-week follow-up: the first interval where changes above the LSC are reliably expected.
• Every 6 months during active therapy: once a therapeutic plateau is reached.
• Annual scan in maintenance: sufficient for patients with stable body weight and no pharmacologic changes.

Key Variables to Report to the Ordering Clinician

A DEXA report submitted to a HealthRX clinician should include: total body fat percentage, total lean mass in kg, ALM in kg, VAT area in cm², android/gynoid fat ratio, lumbar spine T-score, and total hip T-score. A report that only includes "body fat 22%" without lean mass segmentation is not sufficient for clinical decision-making in GLP-1 or TRT management.

The ACSM's 2022 guidelines state: "Body composition testing should be interpreted in the context of clinical history, physical activity level, and concurrent pharmacotherapy, not as a standalone metric" [8]. Scan numbers without clinical context produce incorrect conclusions.